| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Oxaliplatin-Related Posterior Reversible Encephalopathy Syndrome
|
Skelton, Matthew R.
|
|
2007
|
|
5 |
p. 386-388
3 p.
|
artikel
|
| 2 |
Advanced Radiation Therapy Technologies in the Treatment of Rectal and Anal Cancer: Intensity-Modulated Photon Therapy and Proton Therapy
|
Meyer, Jeffrey
|
|
2007
|
|
5 |
p. 348-356
9 p.
|
artikel
|
| 3 |
Aggressive Combined Modality Therapy for Recurrent Colorectal Cancer Involving the Duodenum and Pancreas: A Report of 5 Cases
|
Overman, Michael J.
|
|
2008
|
|
5 |
p. 338-342
5 p.
|
artikel
|
| 4 |
A Phase III Randomized, Open-Label, Controlled Trial of Chemotherapy and Bevacizumab with or Without Panitumumab in the First-Line Treatment of Patients with Metastatic Colorectal Cancer
|
Wainberg, Zev
|
|
2006
|
|
5 |
p. 363-367
5 p.
|
artikel
|
| 5 |
A Phase II Study of Active Immunotherapy with PANVAC™ or Autologous, Cultured Dendritic Cells Infected with PANVAC™ After Complete Resection of Hepatic Metastases of Colorectal Carcinoma
|
Lou, Emil
|
|
2006
|
|
5 |
p. 368-371
4 p.
|
artikel
|
| 6 |
A Retrospective Study of Coagulation Abnormalities in Patients Receiving Concomitant Capecitabine and Warfarin
|
Shah, Heather R.
|
|
2006
|
|
5 |
p. 354-358
5 p.
|
artikel
|
| 7 |
Circulating Endothelial Cells and Circulating Endothelial Cell Progenitors as Surrogate Markers for Determining Response to Antiangiogenic Agents
|
Gupta, Manisha
|
|
2007
|
|
5 |
p. 337-338
2 p.
|
artikel
|
| 8 |
Clinical Colorectal Cancer: New Advances in Screening
|
Chu, Edward
|
|
2006
|
|
5 |
p. 312-
1 p.
|
artikel
|
| 9 |
Clinical Significance of Immunohistochemical Expression of Hypoxia-Inducible Factor–1α as a Prognostic Marker in Rectal Adenocarcinoma
|
Lu, Xue-guan
|
|
2006
|
|
5 |
p. 350-353
4 p.
|
artikel
|
| 10 |
Colorectal Cancer in Patients with Inflammatory Bowel Disease
|
Vagefi, Parsia A.
|
|
2005
|
|
5 |
p. 313-319
7 p.
|
artikel
|
| 11 |
Colorectal Cancer Screening Using Stool DNA Analysis in Clinical Practice: Early Clinical Experience with Respect to Patient Acceptance and Colonoscopic Follow-up of Abnormal Tests
|
Berger, Barry M.
|
|
2006
|
|
5 |
p. 338-343
6 p.
|
artikel
|
| 12 |
Completeness in the Reporting of Dermatologic Adverse Drug Reactions Associated with Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors in Phase II and III Colorectal Cancer Clinical Trials
|
Bauer, Kimberly A.
|
|
2008
|
|
5 |
p. 309-314
6 p.
|
artikel
|
| 13 |
Early Clinical Results from Chemoradiation with 5-Fluorouracil and Oxaliplatin for Locally Advanced Rectal Cancer
|
Lawson, Joshua D.
|
|
2008
|
|
5 |
p. 325-330
6 p.
|
artikel
|
| 14 |
Evolution of FOLFOX Regimens in the Treatment of Advanced Colorectal Cancer
|
Reddy, G. Kesava
|
|
2005
|
|
5 |
p. 296-299
4 p.
|
artikel
|
| 15 |
Expression and Clinical Significance of Methylenetetrahydrofolate Reductase in Patients with Colorectal Cancer
|
Odin, Elisabeth
|
|
2006
|
|
5 |
p. 344-349
6 p.
|
artikel
|
| 16 |
5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study
|
D'Andre, Stacy
|
|
2005
|
|
5 |
p. 325-331
7 p.
|
artikel
|
| 17 |
Hereditary Colorectal Cancer Syndromes: An Overview
|
Kwak, Eunice L.
|
|
2007
|
|
5 |
p. 340-344
5 p.
|
artikel
|
| 18 |
Importance of Preclinical Investigations of the Integration of Capecitabine into Polychemotherapy Regimens
|
Danesi, Romano
|
|
2005
|
|
5 |
p. 344-
1 p.
|
artikel
|
| 19 |
Is Capecitabine Safe in Patients with Gastrointestinal Cancer and Dihydropyrimidine Dehydrogenase Deficiency?
|
Saif, M. Wasif
|
|
2006
|
|
5 |
p. 359-362
4 p.
|
artikel
|
| 20 |
Long-Term Results of Local Excision with and Without Chemoradiation for Adenocarcinoma of the Rectum
|
Wentworth, Stacy
|
|
2005
|
|
5 |
p. 332-335
4 p.
|
artikel
|
| 21 |
Lymphatic Mapping and Sentinel Node Analysis in Colon Cancer
|
Martinez, Steve R.
|
|
2005
|
|
5 |
p. 320-324
5 p.
|
artikel
|
| 22 |
Management of Less Common Tumors of the Colon, Rectum, and Anus
|
Cuffy, Madison
|
|
2006
|
|
5 |
p. 327-337
11 p.
|
artikel
|
| 23 |
Palmar-Plantar Erythrodysesthesia Associated with Scrotal and Penile Involvement with Capecitabine
|
Sapp, Christy M.
|
|
2007
|
|
5 |
p. 382-385
4 p.
|
artikel
|
| 24 |
Polymorphisms in the Thymidylate Synthase Gene Predict Response to 5-Fluorouracil Therapy in Colorectal Cancer
|
Gibson, Tara Beers
|
|
2006
|
|
5 |
p. 321-323
3 p.
|
artikel
|
| 25 |
Radiofrequency Ablation for Patients with Colorectal Cancer and Unresectable Liver Metastasis
|
Gibson, Tara Beers
|
|
2006
|
|
5 |
p. 318-320
3 p.
|
artikel
|
| 26 |
Ribonucleotide Reductase Subunits M2 and p53R2 are Potential Biomarkers for Metastasis of Colon Cancer
|
Liu, Xiyong
|
|
2007
|
|
5 |
p. 374-381
8 p.
|
artikel
|
| 27 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2007
|
|
5 |
p. 389-
1 p.
|
artikel
|
| 28 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2006
|
|
5 |
p. 376-
1 p.
|
artikel
|
| 29 |
Sequential Versus Combination Therapy in the Treatment of Patients with Advanced Colorectal Cancer
|
Shah, Usman
|
|
2008
|
|
5 |
p. 315-320
6 p.
|
artikel
|
| 30 |
Sequential Versus Combination Therapy: Where Are We?
|
Chu, Edward
|
|
2008
|
|
5 |
p. 295-
1 p.
|
artikel
|
| 31 |
Severe Diarrhea in Patients with Advanced- Stage Colorectal Cancer Receiving FOLFOX or FOLFIRI Chemotherapy: The Development of a Risk Prediction Tool
|
Dranitsaris, George
|
|
2007
|
|
5 |
p. 367-373
7 p.
|
artikel
|
| 32 |
Staging of Colorectal Cancer: Past, Present, and Future
|
Horton, Janet K.
|
|
2005
|
|
5 |
p. 302-312
11 p.
|
artikel
|
| 33 |
Synergistic Antitumor Activity of Capecitabine in Combination with Irinotecan
|
Cao, Shousong
|
|
2005
|
|
5 |
p. 336-343
8 p.
|
artikel
|
| 34 |
Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer
|
Sharma, Rohini
|
|
2008
|
|
5 |
p. 331-337
7 p.
|
artikel
|
| 35 |
Targeted Therapy
|
Chu, Edward
|
|
2007
|
|
5 |
p. 336-
1 p.
|
artikel
|
| 36 |
Targeted Therapy in Colorectal Cancer
|
Wadler, Scott
|
|
2007
|
|
5 |
p. 357-361
5 p.
|
artikel
|
| 37 |
The Addition of Bevacizumab to FOLFOX4 Prolongs Survival in Relapsed Colorectal Cancer: Interim Data from the ECOG 3200 Trial
|
Reddy, G. Kesava
|
|
2005
|
|
5 |
p. 300-301
2 p.
|
artikel
|
| 38 |
The Development of the FOLFOX Regimens as a Treatment Standard of Advanced Colorectal Cancer
|
Chu, Edward
|
|
2005
|
|
5 |
p. 292-
1 p.
|
artikel
|
| 39 |
The Role of Immunotherapy in the Treatment of Colorectal Cancer
|
Reddy, G. Kesava
|
|
2006
|
|
5 |
p. 324-326
3 p.
|
artikel
|
| 40 |
Toxicities and Survival Among Octogenarians and Nonagenarians with Colorectal Cancer Treated with Chemotherapy or Concurrent Chemoradiation Therapy
|
Reddy, Nishitha
|
|
2007
|
|
5 |
p. 362-366
5 p.
|
artikel
|
| 41 |
Treatment of Recurrent Metastatic Colon Cancer in the Age of Modern Adjuvant Therapy
|
Kurkjian, Carla
|
|
2008
|
|
5 |
p. 321-324
4 p.
|
artikel
|
| 42 |
Update on Novel Strategies to Optimize Cetuximab Therapy in Patients with Metastatic Colorectal Cancer
|
Macarulla, Teresa
|
|
2008
|
|
5 |
p. 300-308
9 p.
|
artikel
|
Tijdschrift beschrijving